A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation.
Thiyagarajan ThangaveluElizabeth LydenVijay ShivaswamyPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
Our data suggest that GLP-1RA do not affect tacrolimus levels or transplant outcomes in solid organ transplant (SOT) recipients in the short term. GLP-1RA also seem to be as effective in SOT recipients for glycemic control and weight loss as in the non-transplant population with diabetes.
Keyphrases
- glycemic control
- weight loss
- type diabetes
- blood glucose
- bariatric surgery
- rheumatoid arthritis
- roux en y gastric bypass
- insulin resistance
- gastric bypass
- disease activity
- kidney transplantation
- cardiovascular disease
- adipose tissue
- stem cells
- ankylosing spondylitis
- systemic lupus erythematosus
- skeletal muscle
- weight gain
- data analysis
- deep learning
- artificial intelligence